| Literature DB >> 35883033 |
Manman Gao1,2,3, Peng Guo2,3, Xizhe Liu3, Penghui Zhang2, Zhongyuan He2, Liru Wen4, Shaoyu Liu2,3, Zhiyu Zhou5,6, Weimin Zhu7.
Abstract
BACKGROUND: The single-cell platform provided revolutionary way to study cellular biology. Technologically, a sophistic protocol of isolating qualified single cells would be key to deliver to single-cell platform, which requires high cell viability, high cell yield and low content of cell aggregates or doublets. For musculoskeletal tissues, like bone, cartilage, nucleus pulposus and tendons, as well as their pathological state, which are tense and dense, it's full of challenge to efficiently and rapidly prepare qualified single-cell suspension. Conventionally, enzymatic dissociation methods were wildly used but lack of quality control. In the present study, we designed the rapid cycling enzymatic processing method using tissue-specific enzyme cocktail to treat different human pathological musculoskeletal tissues, including degenerated nucleus pulposus (NP), ossifying posterior longitudinal ligament (OPLL) and knee articular cartilage (AC) with osteoarthritis aiming to rapidly and efficiently harvest qualified single-cell suspensions for single-cell RNA-sequencing (scRNA-seq).Entities:
Keywords: Efficiency; Human musculoskeletal tissues; Quality; Single-cell isolation protocol
Mesh:
Substances:
Year: 2022 PMID: 35883033 PMCID: PMC9327421 DOI: 10.1186/s12860-022-00429-2
Source DB: PubMed Journal: BMC Mol Cell Biol ISSN: 2661-8850
Fig. 1Isolation of single cells from degenerated nucleus pulposus (NP) and Single-Cell RNA Sequencing (scRNA-seq). A. Lumber disc degeneration was shown on T2-weighted (T2-WI) Magnetic Resonance Imaging (MRI). The red circle marked the degenerated disc. B. Gross appearance of the degenerated NP obtained from surgery. C. Gross appearance of the cell suspension after 3–5 cycles of enzymatic treatment. Some white floccule residuals were labeled by black circle. D. Total cell numbers were counted automatically and manually, respectively. E. The isolated cell diameter distribution histogram. G. Histogram showing the cell output harvested via the rapid cycling enzymatic processing method (RAPID) or 4-h once-through digestion method (4-HOUR). H. Histogram showing proportion of live cells in each group. I. The live/dead immunofluorescence staining and quantitative analysis. J. Bioanalyzer trace of the scRNA-seq library showed the size distribution between 300 and 600 bp (blue arrow). H. The barcode-rank plot displayed gene expression counts after sequencing
Summary of single-cell isolation protocols for nucleus pulposus in reported studies using scRNA-seq technique
| Reference | Classification of IVD | Species | Treatment | Dead cell removal | Profiling cellular types |
|---|---|---|---|---|---|
| Gan Y, et al. [ | Pfirrmann grade I | Human | TrypLE Express for 30 min, 0.2% pronase (Sigma-Aldrich, USA) for 60 min, and 0.012% collagenase II (Sigma-Aldrich, USA) for 2 ~ 4 h, sequentially | Yes | Chondrocyte, Notochord, Nucleus pulposus progenitor cells, Stromal cell, Pericyte, Endothelial cell and blood cell |
| Fernandes LM, et al. [ | Thompson grade 1 or 2 | Human | Pronase for 1 h and then collagenase P overnight | No Culture cells for scRNA-seq | Cultured nucleus pulposus cells |
| Calió M, et al. [ | Bovine | 0.19% Pronase for 1 h and then 260 IU/mg Collagenase II overnight | No | Nucleus pulposus cells, uncharacterized cell subset, monocyte derived dendritic cells | |
| Zhang Y, et al. [ | Pfirrmann grade I-IV | Human | GEXSCOPETM Tissue Dissociation Solution for 15 min. (Included in the GEXSCOPE® Single Cell RNA library Kit) | No | Chondrocytes, macrophages and endothelial cells |
| Ji Tu, et al. [ | Pfirrmann grade II-V | Human | 500 U/mL collagenase I, 150 U/mL collagenase II, 50 U/mL collagenase IV, 0.1 mg/ml hyaluronidase and 30 U/mL DNaseI for 95 min | Yes | Neucleus pulposus cells, natural killer cells, monocytes, and T cells |
Fig. 2Isolation of single cells from ossifying posterior longitudinal ligament and scRNA-seq. A. Ossification of posterior longitudinal ligament (OPLL) was shown on the three-dimensional reconstruction of computerized tomography (CT) image (red circle). B. Gross appearance of the ossifying posterior longitudinal ligament harvested during surgery. C. Gross appearance of the cell suspension and residuals after 3–5 cycles of enzymatic digestion. D. Stereo microscope images showed the residuals. The red box enclosed some white soft viscous residuals magnified in the image labeled 1. And the yellow box marked part of the bone fragments magnified in the image labeled 2. E. Total cell numbers were counted automatically and manually, respectively. F. The isolated cell diameter distribution histogram. G. The live/dead immunofluorescence staining and quantitative analysis. H. Bioanalyzer trace of the scRNA-seq library showed the size distribution between 300 and 600 bp (blue arrow). I. The barcode-rank plot displayed gene expression counts after sequencing
Fig. 3Rapid isolation of single cells from knee articular cartilage with osteoarthritis (OA) and the quality control. A. OA was characterized on T2-weighted imaging (T2-WI). The affected region was circled in red. B. The isolated cell diameter distribution histogram. C. The live/dead immunofluorescence staining and quantitative analysis. White arrowheads highlighted the cell aggregates, which showed Hoechst 33342+, Calcein+ and PI−
Fig. 4Prolonged isolation of single cells from knee articular cartilage with OA and the quality control. A. The total cell numbers counted automatically in both rapid and prolonged enzymatic treatment groups. Prolonged and continuous digestion would significantly increase cell yield (P < 0.01). B. The isolated cell diameter distribution histogram. C. The live/dead immunofluorescence staining and quantitative analysis. Yellow arrowheads highlighted the cell aggregates, which showed Hoechst 33342+, Calcein− and PI+
Summary of single-cell isolation protocols for cartilage in reported studies using scRNA-seq technique
| Reference | Tissue | Species | Treatment | Number of profiling cells |
|---|---|---|---|---|
| Quanbo Ji, et al. [ | Cartilage from 10 knee OA patients | Human | 0.25% Trypsin–EDTA for 30 min and then 0.2% type II collagenase (Sigma-Aldrich) for 4 h | 1600 |
| Fiorella Carla Grandi, et al. [ | OA samples from patients undergoing total joint replacement | Human | Collagenase II and IV (2.5 mg/ml each; Worthington Biochem) overnight | Not reported |
| Junxiang Li, et al. [ | The distal cartilage structure at postnatal day 7 | Mouse | 0.2% collagenase II for 2 h | 217 |
| Vikram Sunkara, et al. [ | Femur of 12 weeks old mice | Mouse | 10 mg/ml Collagenase II (Nordmark) supplemented for 4 h | 7133 |
| Koji Mizuhashi, et al. [ | Femur growth plate cells at postnatal day 2 | Mouse | Liberase TM (Sigma/Roche) for unclear time | 18,000 |
| Natalie H Kelly, et al. [ | Hindlimb bud of embryonic mice | Mouse | Collagenase Type II (Worthington-biochem, Lakewood, NJ) and pronase (EMD Millipore, Billerica, MA) in 15 min increments with agitation for up to 1 h | 9466 |
Fig. 5Schematic illustration of single cell isolation protocols from different musculoskeletal tissues